Skip to main content
Clinical Trials/NCT05797181
NCT05797181
Completed
Not Applicable

The Effect of Medical Nutrition Therapy on Anthropometric Measurements and Blood Parameters in Sarcopenic Obesity Patients Receiving Peritoneal Dialysis Treatment

Atlas University1 site in 1 country15 target enrollmentFebruary 7, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peritoneal Dialysis Complication
Sponsor
Atlas University
Enrollment
15
Locations
1
Primary Endpoint
Changes of body mass index
Status
Completed
Last Updated
last year

Overview

Brief Summary

In this study, it was aimed to evaluate the effectiveness of medical nutrition therapy to be applied to patients with sarcopenic obesity receiving peritoneal dialysis treatment by measuring anthropometric measurements and blood parameters.

Detailed Description

Efficacy of medical nutrition therapy in patients with sarcopenic obesity receiving peritoneal dialysis treatment, general information form after patients filled in the voluntary consent form, SARC-F questionnaire as sarcopenia screening test, International Physical Activity Questionnaire (IPAQ), muscle mass, muscle strength, physical performance, BIA measurement, anthropometric measurements, laboratory findings and three-day food consumption records will be evaluated.

Registry
clinicaltrials.gov
Start Date
February 7, 2023
End Date
May 15, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Atlas University
Responsible Party
Principal Investigator
Principal Investigator

Ayşe Betül Demirbaş

Principal Investigator

Atlas University

Eligibility Criteria

Inclusion Criteria

  • Volunteering to participate in research
  • Be between the ages of 18-70
  • To receive peritoneal dialysis treatment and to come to the hospital regularly once a month for treatment

Exclusion Criteria

  • Presence of any other disease that causes muscle wasting
  • Patients using any supplement or enteral product in their diet

Outcomes

Primary Outcomes

Changes of body mass index

Time Frame: Baseline to 3 months after diet programme

The weight and height will be combined to report BMI in kg/m2.

Change in the physical performance

Time Frame: Baseline to 3 months after diet programme

4-meter walking speed test will be performed. A walking speed of ≤0.8 m/sec is considered as an indicator of severe sarcopenia.

Change in muscle strength

Time Frame: Baseline to 3 months after diet programme

Handgrip strength (kg) will be measured by using the CAMRY EH101 dynamometer. Hand grip strength \<16 kg for women and \<27 kg for men indicates low muscle strength.

Changes of percentage of body fat

Time Frame: Baseline to 3 months after diet programme

Percentage of body fat will be measured by using bioelectrical impedance analysis.

Change in the skeletal muscle mass

Time Frame: Baseline to 3 months after diet programme

Skeletal muscle mass (kg) will be measured by using bioelectrical impedance analysis.

Change of the fat mass

Time Frame: Baseline to 3 months after diet programme

Fat mass (kg) will be measured by using bioelectrical impedance analysis.

Study Sites (1)

Loading locations...

Similar Trials